Kidney Cancer

>

Latest News

Additional correlative data and further prospective clinical investigations are needed to inform biomarker-directed advanced RCC treatment.
Pembrolizumab Combo Exhibits Sustained Clinical Benefit in Advanced RCC

August 22nd 2025

Additional correlative data and further prospective clinical investigations are needed to inform biomarker-directed advanced RCC treatment.

The biomarker analysis in KEYNOTE-426 showed that pembrolizumab plus axitinib therapy is associated with positive outcomes with angiogenesis in RCC.
Pembrolizumab/Axitinib Improves Survival vs Sunitinib in Advanced RCC

August 1st 2025

Belzutifan Shows Superior Quality-Adjusted Survival in Advanced RCC
Belzutifan Shows Superior Quality-Adjusted Survival in Advanced RCC

July 30th 2025

Personalized kidney cancer vaccines may help guide immune therapies to more effectively attack cancerous cells while mitigating harm to healthy tissue.
Personalized Cancer Vaccines May Transform Treatment Options in Kidney Cancer

July 25th 2025

Collaborators in the Kidney Cancer Research Consortium aim to address mechanistic and scientifically driven questions in the kidney cancer field.
Research Consortium Aims to Accelerate Progress in Kidney Cancer Management

July 25th 2025

Latest CME Events & Activities

More News